Debt-to-Equity

Dana Inc. names Byron Foster its next CEO, signaling a focus on growth and continuity as R. Bruce McDonald remains Chairman amid a major industry shift.

The newly rebranded firm touts record fundraising and a key acquisition, but declining non-GAAP earnings reveal a more complicated financial reality for investors.

The snack giant outpaced the market in 2025 with its core brands, but projects a dip in 2026 earnings despite growth plans and a new buyback program.

Aircraft leasing giant Avolon posts record profits, capitalizing on soaring travel demand and severe aircraft shortages plaguing global airlines.

The Magnum Ice Cream Company's first year post-Unilever shows robust growth, but massive separation costs take a big bite out of profits.

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

Grid Dynamics' new 'Preferred Vendor' status with a top cloud provider validates its role in solving the complex engineering challenges of enterprise AI.

Lincoln International data reveals slowing growth and rising debt distress in private companies, a stark contrast to the heated M&A market for top assets.

Moody's affirms the Estonian energy giant's Baa3 rating, but a negative outlook signals deep-seated risks from its oil shale legacy and market volatility.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

With its foundational drug a success, Madrigal bets billions on next-gen siRNA tech, aiming to fuse it with Rezdiffra and dominate MASH treatment.

Franklin Templeton and Binance launch a landmark program allowing institutions to use tokenized assets as collateral, bridging traditional and digital finance.

With French state backing, Eutelsat secures €1bn to build its next-gen OneWeb LEO constellation, intensifying the global satellite internet race.

With a massive French state-guaranteed financing, Eutelsat is funding a new fleet of 340 Airbus satellites to secure OneWeb's future in the LEO race.

With a 135% revenue surge and a key FDA submission for its kidney transplant drug, Hansa Biopharma is poised for a pivotal year of expansion.

A major new report reveals a deepening crisis in rural healthcare, as a $50 billion federal program clashes with devastating cuts, pushing a vital system to the brink.